| Literature DB >> 31185006 |
Chengjun Zhang1,2, Shengqiang Yu1,2, Binyan Zheng2, Dongfu Liu1,2, Fengchun Wan1,2, Yue Ma1,2, Jiantao Wang1,2, Zhenli Gao1,2, Zhengfei Shan1,2.
Abstract
BACKGROUND Ischemia-reperfusion (I/R) leads to kidney injury. Renal I/R frequently occurs in kidney transplantations and acute kidney injuries. Recent studies reported that miR-30 stimulated immune responses and reductions in renal I/R related to anti-inflammation. Our study investigated the effects of miR-30c-5p on renal I/R and the relationship among miR-30c-5p, renal I/R, and macrophages. MATERIAL AND METHODS Sprague Dawley rats received intravenous tail injections of miR-30c-5p agomir. Then a renal I/R model were established by removing the left kidney and clamping the right renal artery. Serum creatinine (Cr) was analyzed using a serum Cr assay kit, and serum neutrophil gelatinase associated lipocalin (NGAL) was measured using a NGAL ELISA (enzyme-linked immunosorbent assay) kit. Rat kidney tissues were analyzed using hematoxylin and eosin staining. THP-1 cells treated with miR-30c-5p agomir and miR-30c-5p antagomir were measured with quantitative reverse transcription-polymerase chain reaction. Protein levels were analyzed by western blot. RESULTS MiR-30c-5p agomir reduced serum Cr, serum NGAL, and renal I/R injury. MiR-30c-5p agomir inhibited the expression of CD86 (M1 macrophage marker), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-alpha (TNF-alpha) and promoted the expression of CD206 (M2 macrophage marker), interleukin (IL)-4, and IL-10 in rat kidneys. MiR-30c-5p agomir reduced the expression of CD86 and iNOS, and increased the expression of CD206 and IL-10 in THP-1 cells. CONCLUSIONS We preliminarily demonstrated that miR-30c-5p agomir might decrease renal I/R through transformation of M1 macrophages to M2 macrophages and resulted in changes in inflammatory cytokines.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31185006 PMCID: PMC6582680 DOI: 10.12659/MSM.914579
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Oligonucleotide primer sequences for PCR.
| Primer target | Sequence |
|---|---|
| miR-30c-5p | F: 5′-ACACTCCAGCTGGGTGTAAACATCCTACACTC-3′ |
| R: 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTT GAGGCTCAGAG-3′ | |
| U6 | F: 5′-GCTTCGGCAGCACATCTCATAAAAT-3′ |
| R: 5′-CGCTTCACGATTTGCGTGTCAT-3′ | |
| CD86 | F: 5′-TAGGGATAACCAGGCTCTAC-3′ |
| R: 5′-CGTGGGTGTCTTTTGCTGTA -3′ | |
| iNOS | F: 5′-GGAGAGATTTTTCACGACACCC-3′ |
| R: 5′-CCATGCATAATTTGGACTTGCA-3′ | |
| CD206 | F: 5′-GGGACTCTGGATTGGACTCA-3′ |
| R: 5′-CCAGGCTCTGATGATGGACT-3′ | |
| IL-4 | F: 5′-TCGGCATTTTGAACGAGGTC-3′ |
| R: 5′-GAAAAGCCCGAAAGAGTCTC-3′ | |
| IL-10 | F: 5′-CGGGAAGACAATAACTG-3′ |
| R: 5′-CACGCTGGCTCAGCCACTC-3′ | |
| β-actin | F: 5′-ATGGCAACGTCAAGGCTGAGA-3 |
| R: 5′CGCTCCTGGAAGATGGTGAT-3′ | |
| miR-30c-5p | F: 5′-TGTAAACATCCTCGAC-3′ |
| R: 5′-ACATCCAGTGTAGCATA-3′ | |
| U6 | F: 5′-CTTCGGCAGCACATATACTAAAAT-3′ |
| R: 5′-CAGGGGCCATGCTAAATCTTC-3′ | |
| CD86 | F: 5′-TTGCAGAGGCAGCAAGATGG-3′ |
| R: 5′-ATGATGAGTGGCAGCAAGATGG-3′ | |
| iNOS | F: 5′-GGAGCCAGCTCTGCATTATC-3′ |
| R: 5′-TTTTGTCTCCAAGGGACCAG-3′ | |
| CD206 | F: 5′-TTCGGACACCCATCGGAATTT-3′ |
| R: 5′-CACAAGCGCTGCGTGGAT-3′ | |
| IL-10 | F: 5′-CTCGGATCCAAGGCATGCACAGCTCAGC-3′ |
| R: 5′-CTCCTCGAGCCTGATGTCTCAGTTTCGTA-3′ | |
| β-actin | F: 5′-CTGCAGGTCGACGATTGGACTCCGGTGACGGGGTCA-3′ |
| R: 5′-GGATCCTCTAGAGATTATGACCTGGCCGTCAGGCAG-3′ |
Primer target in rat;
Primer target in THP-1 cell line.
Figure 1MiR-30c-5p attenuated rat renal I/R and inhibited serum Cr and serum NGAL. After the rats had surgery to create a rate renal I/R model, the rats were fed normally. Serum samples were taken at 24 hours, 48 hours, and 96 hours after normal feeding. Serum Cr was measured by serum Cr assay kit using automatic chemical analysis at the wavelength of 570 nm (A). Serum NGAL was evaluated by ELISA kit (B). After the rats were sacrificed, the kidney tissues were removed, and the kidney injury was measured by H&E staining (C). MiR-30=miR-30c-5p. The values were presented as mean ±SD, and the data were analyzed by ANOVA with Turkey’s multiple test (a versus Sham group, b versus I/R group; a=b P<0.05, aa=bb P<0.01). I/R – ischemia-reperfusion; Cr – creatinine; NGAL – neutrophil gelatinase associated lipocalin; ELISA – enzyme-linked immunosorbent assay; H&E – hematoxylin and eosin; SD – standard deviation; ANOVA – analysis of variance.
Figure 2Effects of miR-30c-5p on the expression of CD86, CD206, IL-4, IL-10, iNOS, and TNF-α in kidney tissue of rats. After the rats were sacrificed, kidney tissues were removed, and the mRNA of miR-30c-5p, CD86, CD206, IL-4, IL-10, iNOS, and TNF-α were measured by qRT-PCR (A–C, G–J), and the protein levels of CD86 and CD206 were analyzed by western blot (D–F). miR-30=miR-30c-5p. The values were presented as mean ±SD, and the data were analyzed by ANOVA with Turkey’s multiple test (a versus Sham group, b versus I/R group, c versus NC group; a=b=c P<0.05, aa=bb=cc P<0.01). IL – interleukin; iNOS – inducible nitric oxide synthase; TNF-α – tumor necrosis factor-alpha; qRT-PCR – quantitative reverse transcription-polymerase chain reaction; ANOVA – analysis of variance.
Figure 3Effects of miR-30c-5p on the expression of CD86, CD206, iNOS, and IL-10 in THP-1 cells. HTP-1 cells were induced with PMA. Cells were treated with miR-30c-5p agomir and miR-30c-5p antagomir for 3 hours, then the cells were cultured normally for 48 hours. The mRNA levels of miR-30c-5p, CD86, CD206, iNOS, and IL-10 were determined with qRT-PCR (A–E). The protein levels of CD86, CD206, iNOS, and IL-10 were detected with western blot (F–J). miR-30=miR-30c-5p. n=3. The values were presented as mean ±SD, and the data were analyzed by ANOVA with Turkey’s multiple test (a versus Control group; a=b=c P<0.05, aa=bb=cc P<0.01). IL – interleukin; iNOS – inducible nitric oxide synthase; PMA – phorbol myristate acetate; qRT-PCR – quantitative reverse transcription-polymerase chain reaction; SD – standard deviation; ANOVA – analysis of variance.